Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients

This study has been completed.
Information provided by (Responsible Party):
Yoshihide Ueda, Kyoto University Identifier:
First received: April 13, 2009
Last updated: September 2, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)